QSAR Study of Steroid Benchmark and Dipeptides Based on MEDV-13

A molecular electronegativity distance vector based on 13 atomic types, called MEDV-13, is a descriptor for predicting the biological activities of molecules based on the quantitative structure-activity relations (QSAR). The MEDV-13 uses a modified electrotopological state (E-state) index to substitute for the relative eletronegativity (q) of non-hydrogen atoms in the molecule of interest in the MEDV and a topological distance for the relative distance (d) in the MEDV. For an organic molecule containing several chemical elements such as C, H, O, N, S, F, Cl, Br, I, and P, the MEDV-13 includes at best 91 descriptors. Then it is essential to employ a principal component regression (PCR) technique to derive a QSAR model relating the biological activities to the MEDV-13. The MEDV-13 is used to study the QSAR of the corticosteroid-binding globulin (CBG) binding affinity of the steroids and the activity inhibiting angiotensin-converting enzyme (ACE) of dipeptides, and resulting models have a comparable quality to the current three-dimensional (3D) methods such as CoMFA though the MEDV-13 is a descriptor based on two-dimensional topological information.

[1]  S J Peterson,et al.  QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. , 1993, Journal of medicinal chemistry.

[2]  Catherine Burt,et al.  The application of molecular similarity calculations , 1990 .

[3]  A. Wozniak,et al.  Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines. , 1993, Journal of medicinal chemistry.

[4]  Roberto Todeschini,et al.  MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids , 1997, J. Comput. Aided Mol. Des..

[5]  G. Cruciani,et al.  Predictive ability of regression models. Part II: Selection of the best predictive PLS model , 1992 .

[6]  Julie C. Mitchell,et al.  Determination of receptor-bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index , 1996, J. Comput. Aided Mol. Des..

[7]  M. Karelson,et al.  Structurally diverse quantitative structure--property relationship correlations of technologically relevant physical properties , 2000, Journal of chemical information and computer sciences.

[8]  W. Richards,et al.  Self-organizing molecular field analysis: a tool for structure-activity studies. , 1999, Journal of medicinal chemistry.

[9]  A. Good,et al.  Structure-activity relationships from molecular similarity matrices. , 1993, Journal of medicinal chemistry.

[10]  Richards Wg,et al.  QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. , 1993 .

[11]  Ulf Norinder,et al.  3D‐QSAR investigation of the tripos benchmark steroids and some protein‐tyrosine kinase inhibitors of styrene type using the TDQ approach , 1996 .

[12]  Ramon Carbo,et al.  How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .

[13]  A. Seri-Levy,et al.  Shape similarity as a single independent variable in QSAR , 1994 .

[14]  G Klebe,et al.  On the prediction of binding properties of drug molecules by comparative molecular field analysis. , 1993, Journal of medicinal chemistry.

[15]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[16]  A. N. Jain,et al.  Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. , 1994, Journal of medicinal chemistry.

[17]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[18]  G. Cruciani,et al.  Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. , 1994, Journal of medicinal chemistry.

[19]  Lemont B. Kier,et al.  Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..

[20]  Lemont B. Kier,et al.  The Electrotopological State: An Atom Index for QSAR , 1991 .

[21]  Garland R. Marshall,et al.  3D-QSAR of angiotensin-converting enzyme and thermolysin inhibitors: A comparison of CoMFA models based on deduced and experimentally determined active site geometries , 1993 .

[22]  Lemont B. Kier,et al.  An index of electrotopological state for atoms in molecules , 1991 .

[23]  Lemont B. Kier,et al.  Comparison of electrotopological state indexes with molecular orbital parameters : inhibition of MAO by hydrazides , 1993 .

[24]  Chenzhong Cao,et al.  Molecular Distance—Edge Vector (μ): An Extension from Alkanes to Alcohols. , 2000 .

[25]  R Benigni,et al.  Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications. , 1995, Journal of medicinal chemistry.

[26]  Lemont B. Kier,et al.  QSAR modeling with the electrotopological state indices: Corticosteroids , 1998, Journal of computer-aided molecular design.

[27]  Liu Shu.  A Novel Molecular Electronegativity-Distance Vector (MEDV) , 2000 .

[28]  Andrea Zaliani,et al.  MS-WHIM Scores for Amino Acids: A New 3D-Description for Peptide QSAR and QSPR Studies , 1999, J. Chem. Inf. Comput. Sci..

[29]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[30]  Yu Chen,et al.  Evaluation of Quantitative Structure-Activity Relationship Methods for Large-Scale Prediction of Chemicals Binding to the Estrogen Receptor , 1998, J. Chem. Inf. Comput. Sci..